Wako GOT II - HA
510(k) K864302
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK864302 | Date16 Dec 1986 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Wako(Tm) Got II - Ha
- 510(k) Number
- FDA Product Code
- CIT
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1100
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 27 Sep 2026
The Wako GOT II - HA is a clinical chemistry device categorized as a NADH oxidation/NAD reduction, AST/SGOT test. It is designed for use in clinical chemistry applications.
This device is subject to FDA 510(k) clearance under the regulation number 862.1100. It is classified as a Class II device.
Other devices from Wako Chemicals USA, Inc.
Questions
AI-generated answers, 27 Sep 2026
What is the primary function of the Wako GOT II - HA?
The Wako GOT II - HA is a clinical chemistry device specifically designed for AST/SGOT testing. It functions by facilitating NADH oxidation and NAD reduction processes within clinical chemistry applications.
What is the regulatory classification of this device?
The Wako GOT II - HA is classified as a Class II medical device. It has received FDA 510(k) clearance under regulation number 862.1100, which pertains to clinical chemistry test systems.
Who is the manufacturer of the Wako GOT II - HA?
This device is manufactured by Wako Chemicals USA, Inc., located in Dallas, Texas. The product is identified by the K-number K864302.